Breaking the Speed Limits of Biology

From evolutionary constraint to competitive advantage.

We’ve long accepted biology’s speed as a fixed constraint. But what if these limits reflect only the solutions that survived, not the boundaries of what’s possible? As biology becomes more engineerable, we see a venture opportunity hiding in plain sight: an asymmetric opportunity to back companies that leverage biological acceleration to fundamentally restructure the economics of entire industries.

Written by Jennifer Kan, PhD

---

In software, speed is a feature. In biology, speed is often perceived as a constraint.

Fast-growing bacteria like E. coli can double in 20 minutes under optimal conditions. Yeast in 90 minutes. Mammalian cells? 12–24 hours. We can’t make products faster than cells divide and grow. We accept this as the fundamental limit of biology.

But is it?

We observe existing biological systems and assume they represent the limits of what’s possible, but we’re only seeing the solutions that survived. Perhaps faster biological systems existed but were selected against in the natural world because speed carried hidden costs—higher energy consumption, increased error rates, or reduced robustness.

Historically, biology has been a discipline to be studied. It’s observational, descriptive, and takes a long time to understand. Today, we’re entering an era where biology can be engineered, and is even programmable. This is an era where the speed of biology is defined not by survival of the fittest, but by the law of physics and human creativity.

The venture case of accelerating biology

In venture, time is money and speed compounds. At Juniper, we believe breaking the perceived speed limits of biology represents the rare opportunity to invest in technologies that don’t just create new products, but fundamentally restructure the economics of entire industries. The time savings enabled by faster biology could compress research and development timelines, mitigate risk through faster iteration, reduce time to market, and ultimately improve the capital efficiency of commercialization.

Speed advantages in biology are frequently highly defensible. Unlike software where competitors can often replicate features quickly, biological speed improvements require deep technical expertise. The first companies to achieve significant biological acceleration will likely maintain substantial competitive moats.

Importantly, companies that solve biological speed constraints don’t just create products, they become central nodes in our economy, capable of accelerating multiple markets and capturing value across entire ecosystems. A company with 100x faster protein production capabilities, for example, could address a trillion-dollar opportunity across pharmaceuticals, food, materials, and cosmetics markets. This platform approach creates the kind of massive addressable markets and multiple expansion paths that generate venture-scale returns.

Frontiers we’re tracking

Given these economic advantages, we are excited by technologies that defy biology’s perceived speed limits. We believe this requires us to think beyond the conventional boundaries of any single discipline. The most powerful solutions will likely emerge from the convergence of multiple technological frontiers. Here are opportunities we are paying attention to:

• Context Engineering

The speed of biology isn’t just determined by cells and molecules, it’s also shaped by the context in which biology operates. Could we better engineer localized environments or micro-compartments that alter the physical and chemical conditions biology operates in? How could we manipulate electromagnetic, acoustic, or gravitational fields to guide biological systems to our advantage? For example, synthetic organelles that concentrate substrates 1000x above normal cellular levels, or electromagnetic fields that guide molecular assembly in ways impossible in natural environments.

• Hybrid Systems

Biology can operate with greater speed and control when integrating with complementary technologies. Optogenetics already demonstrates this principle, enabling microsecond control of gene expression—1000-fold faster than chemical signaling—by coupling light with biological systems. Bio-electronic systems can sense biological signals, deliver electrical stimulation, or even perform computation faster than biology. Chemo-enzymatic systems can outperform either chemistry or biocatalysis alone in speed and selectivity in how we make molecules. These convergences are redefining what’s possible when biology is part of a larger, optimized system rather than operating in isolation.

• Molecular Engineering

At the foundation of biological speed lies the molecular machinery of life itself. Advanced molecular engineering lets us rebuild that machinery. Some engineered enzymes already exceed natural limits by orders of magnitude—artificial proteases that cut proteins 100x faster than their natural counterparts, or synthetic DNA polymerases that replicate at speeds approaching theoretical limits. With the rise of AI, genetic engineering tools, and automation we see unprecedented opportunities in accelerating gene expression, molecular synthesis, and cell growth. These advances enable biological systems to operate on timescales previously considered impossible.

The transformation ahead

These three technological frontiers converge on a single transformative capability: the compression of time. While technical risk remains substantial, the potential returns are asymmetric. Success doesn’t just create new products, it creates entirely new categories of what’s possible. Imagine when biological processes that normally take hours can be completed in minutes, and we can run millions of these processes simultaneously with state-of-the-art automation, what could we build with this capability?

If you’re building in this space, we want to hear from you!